sur ABSCIENCES (EPA:AB)
AB Science postpones the publication of its 2024 annual financial report
AB Science SA, a company listed on Euronext Paris, announced that the publication of its 2024 annual financial report has been postponed to May 9, 2025. Initially scheduled for April 30, 2025, this decision was made to allow the statutory auditors to finalize their audit work. The publication will take place after the market closes.
AB Science specializes in the development of protein kinase inhibitors, a key technology in the treatment of serious pathologies. The company, founded in 2001, is headquartered in Paris. Masitinib, its flagship molecule, is the subject of promising developments in several medical fields.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ABSCIENCES